Associate Director of Academic Development and Emory University's Winship Cancer Institute in Atlanta and Professor of Hematology and Oncology, Medicine, Otolaryngology, and Pharmacology at Emory's School of Medicine, Dong M. Shin, MD, received his medical degree from Yonsei University School of Medicine in his native Seoul, Korea. He completed both his internship and residency at Cook County Hospital in Chicago, Illinois both in internal medicine, and his fellowship in Hematology and Oncology at the MD Anderson Cancer Center at the University of Texas in Houston. He is board certified in internal medicine and medical oncology.

Dr. Shin lists his clinical interests as the treatment and prevention of various types of cancer including head and neck cancers, thymoma, lung cancer and mesothelioma. As a researcher, Dr. Shin has worked on developing new therapies and prevention strategies for mesothelioma, lung cancers, head and neck cancers, and thymoma. In addition, his research has included establishing a carcinogenesis model in preclinical and clinical settings for head, neck, and lung cancer, developing biomarkers in animal and human carcinogenesis for head, neck and lung cancer, and developing molecular targeted prevention and therapies using interferons, retinoids, epidermal growth factor receptor (EGFR) signaling pathways, COX-2 inhibitors and other molecular targeted molecules.

Dr. Shin is a member of the American Association for Cancer Research and the American Society of Clinical Oncology and is a fellow of the American College of Physicians and the American Society of Head and Neck Surgery. Honors received by Dr. Shin include the Award of Clinical Oncology Career Development issued by the American Cancer Society in 1991 and the Faculty Scholar Award from the M.D. Anderson Cancer Center in 2000.

As an author and co-author, Dr. Shin has written more than 150 articles, books and book-chapters, many of them peer-reviewed and printed in the most prestigious medical journals.

Contact Information:
Emory University School of Medicine, Winship Cancer Institute
1365 Clifton Road
Room 3090, Building C
Atlanta, Georgia 30322
Phone: 404-778-5990

Doctor Match Program

One of the most important factors in improving a mesothelioma patient's life expectancy is their selection of doctor and treatment facility. Asbestos.com's Doctor Match Program is now helping patients get matched with top mesothelioma specialists around the country. If you wish to take advantage of this free service please call us at (800) 549-0544 or click here visit our doctor match page.

Two must read books for anyone who has or who is caring for someone with mesothelioma.

Get a Free Copy of Lean on Me or 100 Questions & Answers About Mesothelioma.

Asbestos.com has experienced navy veterans on staff to assist veterans in answering questions about applying for asbestos-related VA Claims and other benefits.

*Asbestos.com is not affiliated with the
U.S. Department. of Veterans Affairs.

Naval Ships Index
Search through our extensive list of ships that used asbestos-containing products.
(e.g. USS Alabama BB 60)

Get matched with the top mesothelioma specialists in your area.

Learn what foods to eat, which to avoid, and the best supplements for the fight against cancer and chemotherapy recovery.

Pleural Mesothelioma May Have New Biomarker
09/01/2010 - In a recent article published in the online publication Modern Pathology, researchers may have found a new biomarker for malignant pleural mesotheliom..
Mesothelioma-Causing Asbestos May be Banned in Taiwan
08/31/2010 - According to a news report, Taiwan's Environmental Protection Agency (EPA) has plans to phase out the use of asbestos within the next decade. Lin C..
Mesothelioma Risk in Schools Can Be Managed
08/30/2010 - Seven schools in Virginia Beach, Virginia built between 1956 and 1974 have been found to contain a small amount of asbestos in sealants applied to the..